Osaic Holdings’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.6K Sell
1,875
-723
-28% -$18.7K ﹤0.01% 5280
2025
Q4
$66K Sell
2,598
-33
-1% -$736 ﹤0.01% 5043
2025
Q3
$42.3K Sell
2,631
-78
-3% -$1.26K ﹤0.01% 5420
2025
Q2
$43.5K Sell
2,709
-207
-7% -$3.13K ﹤0.01% 5155
2025
Q1
$49.8K Buy
2,916
+646
+28% +$13.5K ﹤0.01% 4716
2024
Q4
$56.2K Buy
2,270
+7
+0.3% +$199 ﹤0.01% 4614
2024
Q3
$64.5K Buy
2,263
+678
+43% +$20K ﹤0.01% 4560
2024
Q2
$41.8K Buy
1,585
+64
+4% +$1.82K ﹤0.01% 4812
2024
Q1
$49.1K Sell
1,521
-2,422
-61% -$88.4K ﹤0.01% 4764
2023
Q4
$166K Buy
3,943
+1,015
+35% +$37.4K ﹤0.01% 4078
2023
Q3
$112K Sell
2,928
-72
-2% -$1.63K ﹤0.01% 4418
2023
Q2
$56.9K Hold
3,000
﹤0.01% 4852
2023
Q1
$46.5K Hold
3,000
﹤0.01% 5002
2022
Q4
$53K Hold
3,000
﹤0.01% 4887
2022
Q3
$17K Hold
3,000
﹤0.01% 5700
2022
Q2
$12K Hold
3,000
﹤0.01% 5965
2022
Q1
$17K Sell
3,000
-26
-0.9% -$162 ﹤0.01% 5811
2021
Q4
$26K Sell
3,026
-30
-1% -$248 ﹤0.01% 5611
2021
Q3
$26K Buy
+3,056
New +$27.6K ﹤0.01% 5589
2021
Q1
Sell
-26
Closed -$1K 6870
2020
Q4
$1K Hold
26
﹤0.01% 6220
2020
Q3
$1K Buy
+26
New +$782 ﹤0.01% 6016

Other funds holding IMVT

Osaic Holdings's IMVT Position: Q1 2026 in Review

Osaic Holdings reduced its Immunovant (IMVT) stake by 28% in Q1 2026, selling an estimated $18.7K and leaving 1,875 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5280.

Osaic Holdings first reported a position in IMVT in Q3 2020 and has held it in 21 quarters since. The position peaked at $166K in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Osaic Holdings held 1,875 shares of Immunovant worth $46.6K as of Q1 2026.
  • Osaic Holdings sold 723 Immunovant shares in Q1 2026, an estimated $18.7K.
  • Immunovant made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5280 holding.
  • Osaic Holdings first reported a position in Immunovant in Q3 2020 and has held it in 21 quarters since.
  • Osaic Holdings's Immunovant position peaked at $166K in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.